Skip to main content
  • Home
  • About Us
  • Advisory Board
  • Advertise
  • Editorial Submissions
  • Contact Us

  • Get The Newsletter!
  • View The Latest Newsletter
  • Follow me on Twitter
  • Friend me on Facebook
  • Connect with me on LinkedIn
  • Subscribe to me on YouTube
  • Subscribe to my RSS Feed

Menu

Skip to content
  • Digital Health
  • MedTech Economics
  • Manufacturing Execution
  • Product Design & Development
  • Quality/Regulatory
  • Resource Centers
    • Post-Market Surveillance Resource Center
    • MedTech Regulatory Management (RIM) Resource Center
    • EU MDR and IVDR Resource Center
    • Medical Device Design & Manufacturing Resource Center
  • Events & Webinars
  • Library

Market Access

March 3, 2015

Johnson & Johnson to Sell Cordis to Cardinal Health for $1.94 billion.

Cardinal CEO George Barrett has said that the company may make more acquisitions in cardiology and endovascular treatment as well as in the trauma and wound care segment.

Continue reading →

February 25, 2015
Ameing for Asia

Hopes and Hurdles for Medical Device Companies in China in the Year of the Ram

By Ames Gross

There are great opportunities for foreign medical device companies in China as the people want better healthcare, the government is increasing access to healthcare, and the market is growing between 15 and 20 percent per year. But access to the marketplace is harder than ever. Why?

Continue reading →

February 25, 2015

Cardinal to buy J&J’s Cordis Unit?

By MedTech Intelligence Staff

Bloomberg reports that the world’s largest healthcare company Johnson & Johnson is in talks with Cardinal Health Inc. to sell its Cordis unit. The unit may fetch as much as $2 billion in a sale, according to the story.

Continue reading →

February 18, 2015

Medtronic Posts Higher-Than-Expected Q3 Profits

By MedTech Intelligence Staff

The company’s heart devices such as implantable defibrillators, artificial valves and devices to treat atrial fibrillation, contributed to a 5 percent increase in sales in the cardiac and vascular business, its largest unit.

Continue reading →

February 18, 2015

Med-tech Deal Activity Remained Strong in Q4

By MedTech Intelligence Staff

According to recent analysis by PwC, deal volume declined from 13 deals in the third quarter of 2014 to 9 deals in the fourth quarter. However, deal value increased from $3.7 billion to $4.9 billion over the same period.

Continue reading →

February 11, 2015

New Japan Medical Device Regulations

By Ames Gross

The new PMD Act was based on previous ordinances implemented in the summer of 2014. Two of the main points of this revision are to increase safety measures for medical devices and introduce new cellular and tissue therapeutic product regulations.

Continue reading →

February 4, 2015

“Tax Effect Not Minimal and is Responsible for 18,500 Job Losses”

The medical device tax has a “profound negative effect” on the nation’s jobs and innovation, AdvaMed President and CEO Stephen Ubl and Medical Imaging & Technology Alliance Executive Director Gail Rodriguez explain in an editorial.

Continue reading →

February 3, 2015

Roche and Qualcomm Collaborate to Innovate Remote Patient Monitoring

Many remote patient monitoring and management solutions today require patients to communicate results to their health care professionals in manual, time-consuming and non-digitized channels. Qualcomm Life and Roche hope to create an improved process for sharing health information between health care providers and their patients.

Continue reading →

February 3, 2015
Reimbursement Report

A Major National Health Plan Medical Director Shares Insights on How Coverage Decisions are Made

By Jessica Holmes

This Q&A session, with an active Regional Medical Director involved in traditional health plan policy and payment development, as well as emerging value-based models, reveals important information and attitudes toward coverage of new/existing technologies and standards of evidence.

Continue reading →

February 3, 2015

Global Market for Refurbished Devices Will Reach $9.37 B by 2019

New market research report also notes that growth has been restricted by a lack of standardization of policies related to the reuse of medical devices and the hesitancy of some organizations to purchase refurbished medical equipment.

Continue reading →

Post navigation

  • Previous
  • 1
  • …
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • Next

Upcoming Events & Webinars

No posts found.



On Demand Events & Webinars

No posts found.






Columns

March 21, 2025

IVD Intended Purpose:
Why it matters more than ever under IVDR

By Dr. Oliver Eikenberg
IVDR

Under IVDR, clear and specific IVD intended use criteria are required and introduce significant challenges for manufacturers seeking CE Marking and global market access. With updated compliance deadlines approaching, how can manufacturers manage risk and avoid regulatory delays and disruptions in their market strategies?

March 21, 2025

IVD Intended Purpose:
Why it matters more than ever under IVDR

By Dr. Oliver Eikenberg
IVDR

Clear and specific IVD intended use criteria are required and introduce significant challenges for manufacturers seeking CE Marking and global market access. With IVDR compliance deadlines approaching, how can manufacturers manage risk and avoid regulatory delays and disruptions in their market strategies?

October 31, 2024

Japan Medical Device Reimbursement Update 2024

By Ames Gross

Medical Device reimbursement levels in Japan are now more in line with the reimbursement levels in the EU. The Japanese government has pledged not to allow Japanese device reimbursement to be as high as the US prices.

June 30, 2024

FDA publishes long-awaited clinical trial diversity guidance

By Hogan Lovells Engage
FDA

An analysis from the Life Sciences legal team at Hogan Lovells.

March 6, 2024

Overcoming Forecasting Challenges in Cell and Gene Therapies

By Sanobar Syed
Sanobar Syed

Predicting the potential of cell and gene therapy pipelines presents unique challenges. Following are considerations for forecasters working with novel technologies.

November 29, 2023

Medcrypt Appoints Former FDA Officer to Vice President of Services

Naomi Schwartz

“We’re excited to have Naomi in this role. With her FDA experience, her visionary approach will pave the way for success, ensuring that businesses not only meet the FDA's stringent requirements but also thrive in an environment where cybersecurity is a fundamental business value.”

November 15, 2023
Soapbox

Unlocking Success in SaMD Product Launches Through AI

By Caroline Shleifer
Caroline Shleifer

AI-driven regulatory platforms support SaMD organizations by proactively monitoring and adapting to the dynamic global regulatory landscape. The technology alerts users to anticipated regulatory updates worldwide, facilitating improved foresight and trend detection. It also provides guidance on addressing potential lapses in product compliance, integrates with existing workflows and streamlines regulatory tasks from classification to registration and market entry.

November 1, 2023

Drivers and Implications of Multi-Billion Dollar Acquisitions in Medtech

By Laurie Halloran, Maria Shepherd
Puzzle piece

While billion-dollar deals are common in the medtech industry, multi-billion-dollar megadeal acquisitions were still notable in 2022. Often, these deals result in a ripple effect on the industry when two large companies merge. Here we look at some recent examples, the growth drivers behind them and what they mean for the medtech industry.

  • Digital Health
  • MedTech Economics
  • Manufacturing Execution
  • Product Design & Development
  • Quality/Regulatory

Upcoming Events & Webinars

No posts found.



On Demand Events & Webinars

No posts found.


Combination Products

Contact Us

  • Advertising Opportunities
  • Editorial Submissions
  • General Inquiries
  • Privacy Policy
  • Cookie Policy
  • Sign Up for Newsletters

Innovative Publishing Company, Inc.

  • FoodSafetyTech
  • Food Safety Consortium Conference & Expo
  • MedTech Intelligence
  • Cannabis Industry Journal

© Copyright 2015 - 2025 Innovative Publishing Co., Inc., All Rights Reserved

Other Innovative Publishing Co., Inc. Sites: Food Safety Tech  |  Cannabis Industry Journal

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

MedTech Intelligence
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

We use tracking pixels that set your arrival time at our website, this is used as part of our anti-spam and security measures. Disabling this tracking pixel would disable some of our security measures, and is therefore considered necessary for the safe operation of the website. This tracking pixel is cleared from your system when you delete files in your history.

We also use cookies to store your preferences regarding the setting of 3rd Party Cookies.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Cookie Policy

A browser cookie is a small piece of data that is stored on your device to help websites and mobile apps remember things about you. Other technologies, including Web storage and identifiers associated with your device, may be used for similar purposes. In this policy, we say “cookies” to discuss all of these technologies.

Our Privacy Policy explains how we collect and use information from and about you when you use This website and certain other Innovative Publishing Co LLC services. This policy explains more about how we use cookies and your related choices.

How We Use Cookies

Data generated from cookies and other behavioral tracking technology is not made available to any outside parties, and is only used in the aggregate to make editorial decisions for the websites. Most browsers are initially set up to accept cookies, but you can reset your browser to refuse all cookies or to indicate when a cookie is being sent by visiting this Cookies Policy page. If your cookies are disabled in the browser, neither the tracking cookie nor the preference cookie is set, and you are in effect opted-out.

In other cases, our advertisers request to use third-party tracking to verify our ad delivery, or to remarket their products and/or services to you on other websites. You may opt-out of these tracking pixels by adjusting the Do Not Track settings in your browser, or by visiting the Network Advertising Initiative Opt Out page.

You have control over whether, how, and when cookies and other tracking technologies are installed on your devices. Although each browser is different, most browsers enable their users to access and edit their cookie preferences in their browser settings. The rejection or disabling of some cookies may impact certain features of the site or to cause some of the website’s services not to function properly.

Individuals may opt-out of 3rd Party Cookies used on IPC websites by adjusting your cookie preferences through this Cookie Preferences tool, or by setting web browser settings to refuse cookies and similar tracking mechanisms. Please note that web browsers operate using different identifiers. As such, you must adjust your settings in each web browser and for each computer or device on which you would like to opt-out on. Further, if you simply delete your cookies, you will need to remove cookies from your device after every visit to the websites. You may download a browser plugin that will help you maintain your opt-out choices by visiting www.aboutads.info/pmc. You may block cookies entirely by disabling cookie use in your browser or by setting your browser to ask for your permission before setting a cookie. Blocking cookies entirely may cause some websites to work incorrectly or less effectively.

The use of online tracking mechanisms by third parties is subject to those third parties’ own privacy policies, and not this Policy. If you prefer to prevent third parties from setting and accessing cookies on your computer, you may set your browser to block all cookies. Additionally, you may remove yourself from the targeted advertising of companies within the Network Advertising Initiative by opting out here, or of companies participating in the Digital Advertising Alliance program by opting out here.